Pablo Martínez

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

Myung‐Ju Ahn, Byoung Chul Cho, Enriqueta Felip et al. · New England Journal of Medicine · 2023 · 482 citations

Medicine, Oncology, Pharmacology +16

Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer

S. Cedrés, Davis Y. Torrejon, A. Martínez et al. · Clinical & Translational Oncology · 2012 · 304 citations

Medicine, Oncology, Pathology +11

Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)

S. Cedrés, Santiago Ponce-Aix, Jon Zugazagoitia et al. · PLoS ONE · 2015 · 219 citations · Full text

Medicine, Cancer Biology, Oncology +16

Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)

S. Cedrés, Isaac Núñez, Marina Longo et al. · Clinical Lung Cancer · 2011 · 213 citations

Medicine, Oncology, Neoplasia +8

Fully Online Multicommand Brain-Computer Interface with Visual Neurofeedback Using SSVEP Paradigm

Pablo Martínez, Hovagim Bakardjian, Andrzej Cichocki · Computational Intelligence and Neuroscience · 2007 · 208 citations · Full text

Engineering, Computer Science, Neuroscience +17